SFI
FBIO icon

Susquehanna Fundamental Investments’s Fortress Biotech FBIO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-939
Closed -$12K – 1285
2022
Q3 		$12K Buy
+939
New +$14.1K ﹤0.01% 1413
2022
Q1 		$54K Hold
2,666
– – ﹤0.01% 1488
2021
Q4 		$100K Buy
+2,666
New +$119K ﹤0.01% 1334

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's FBIO Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Fortress Biotech (FBIO) in Q4 2022, closing a stake of 939 shares — an estimated $12K sold.

Susquehanna Fundamental Investments first reported a position in FBIO in Q4 2021 and held it in 3 quarters. The position peaked at $100K in Q4 2021. 49 funds tracked by Wall St. Rank hold FBIO as of Q4 2022.

  • Susquehanna Fundamental Investments reported no remaining Fortress Biotech position as of Q4 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 939 Fortress Biotech shares in Q4 2022, an estimated $12K.
  • Susquehanna Fundamental Investments first reported a position in Fortress Biotech in Q4 2021 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's Fortress Biotech position peaked at $100K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.